Alphatec Holdings (ATEC) Cash from Financing Activities (2010 - 2026)
Alphatec Holdings' (ATEC) quarterly Cash from Financing Activities came in at -$1.8 million in Q1 2026, down 105.77% year-on-year from $30.8 million in Q1 2025, and down 961.17% quarter-over-quarter from $206000.0 in Q4 2025.
Alphatec Holdings (ATEC) Cash from Financing Activities (2010 - 2026) Analysis & Trends
Alphatec Holdings has disclosed Cash from Financing Activities across 17 years of filings, most recently posting -$1.8 million for Q1 2026.
- Cash from Financing Activities for Q1 2026 came in at -$1.8 million, down 105.77% year-over-year; the trailing twelve-month figure through Mar 2026 was -$2.5 million (down 102.75% YoY), and the FY2025 annual result was $30.0 million, down 46.59% from the prior year.
- Cash from Financing Activities came in at -$1.8 million for Q1 2026 at Alphatec Holdings, down from $206000.0 in the prior quarter.
- In the past five years, Cash from Financing Activities ranged from a high of $151.6 million in Q4 2023 to a low of -$4.4 million in Q1 2024.
- The 5-year median for Cash from Financing Activities is $3.2 million (2024), against an average of $27.8 million.
- Across the five-year window, Cash from Financing Activities soared 14862.59% in 2023 and tumbled 119.61% in 2025, its largest moves.
- Alphatec Holdings' Cash from Financing Activities stood at $1.0 million in 2022, then jumped by 14862.59% to $151.6 million in 2023, then sank by 66.59% to $50.6 million in 2024, then tumbled by 99.59% to $206000.0 in 2025, then slumped by 961.17% to -$1.8 million in 2026.
- The last three Cash from Financing Activities figures came in at -$1.8 million (Q1 2026), $206000.0 (Q4 2025), and -$1.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 17.31 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | -1.51 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | -2.09 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | -260.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | -451.20 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -26.93 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | -25.00 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 21.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | -97.90 Mn |
| 10 | Alphatec Holdings | 1.34 Bn | 1.20 Bn | 136.48 Mn | -1.77 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.77 Mn |
| Mar 31, 2026 | -1.77 Mn |
| Dec 31, 2025 | 206,000.00 |
| Dec 31, 2025 | 206,000.00 |
| Sep 30, 2025 | -1.31 Mn |
| Sep 30, 2025 | -1.31 Mn |
| Jun 30, 2025 | 366,000.00 |
| Jun 30, 2025 | 366,000.00 |
| Mar 31, 2025 | 30.76 Mn |
| Mar 31, 2025 | 30.76 Mn |
| Dec 31, 2024 | 50.64 Mn |
| Dec 31, 2024 | 50.64 Mn |
| Sep 30, 2024 | 6.69 Mn |
| Sep 30, 2024 | 6.69 Mn |
| Jun 30, 2024 | 3.24 Mn |
| Jun 30, 2024 | 3.24 Mn |
| Mar 31, 2024 | -4.37 Mn |
| Mar 31, 2024 | -4.37 Mn |
| Dec 31, 2023 | 151.57 Mn |
| Dec 31, 2023 | 151.57 Mn |